TET2 and diffuse large B-cell lymphoma: TET2 deficiency in diffuse large B-cell lymphoma (DLBCL) leads to hypermethylation in germinal center B-cells and links to transcriptional repression of antigen presentation genes or interferon pathway genes via promoter hypermethylation and loss of enhancer 5hmC (Rosikiewicz et al. 2020).